Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation

Transplantation

Volumn 102, Issue 10, 2018, Pages 1710-1716

  Allen, Alina M ^a   Heimbach, Julie K ^a   Larson, Joseph J ^a   Mara, Kristin C ^a   Kim, W Ray ^b   Kamath, Patrick S ^a   Therneau, Terry M ^a  

^a MAYO CLINIC   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; GLOMERULUS FILTRATION; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MALE; MORTALITY RATE; PRIORITY JOURNAL; RISK FACTOR; BLOOD; COMPARATIVE STUDY; GLOMERULUS FILTRATION RATE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HOSPITAL ADMISSION; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; RESOURCE ALLOCATION; SEVERITY OF ILLNESS INDEX; SEX FACTOR; STANDARDS; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION;

COHORT STUDIES; CREATININE; END STAGE LIVER DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; KIDNEY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RESOURCE ALLOCATION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 85054327782     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000002196     Document Type: Article

References (20)

1. Moylan CA, Brady CW, Johnson JL, et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300: 2371-2378.
2. Mathur AK, Schaubel DE, Gong Q, et al. Sex-based disparities in liver transplant rates in the United States. Am J Transplant. 2011;11:1435-1443.
3. Lai JC, Terrault NA, Vittinghoff E, et al. Height contributes to the gender difference inwait-list mortality under theMELD-based liver allocation system. Am J Transplant. 2010;10:2658-2664.
4. Bryce CL, Angus DC, Arnold RM, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9: 2092-2101.
5. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores - a systematic bias. Am J Transplant. 2007;7:685-692.
6. Huo SC, Huo TI, Lin HC, et al. Is the corrected-creatinine model for endstage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation? Transplantation. 2007;84:1406-1412.
7. Mindikoglu AL, Regev A, Seliger SL, et al. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010; 16:1147-1157.
8. Myers RP, Shaheen AA, Aspinall AI, et al. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462-470.
9. Mindikoglu AL, Emre SH, Magder LS. Impact of estimated liver volume and liver weight on gender disparity in liver transplantation. Liver Transpl. 2013;19:89-95.
10. Bowring MG, Ruck JM, Haugen CE, et al. Deceased-donor liver size and the sex-based disparity in liver transplantation. Transplantation. 2017; 101:e329.
11. Axelrod DA, Pomfret EA. Race and sex disparities in liver transplantation: progress toward achieving equal access? JAMA. 2008;300:2425-2426.
12. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825-832.
13. Parikh-Patel A, Gold EB, Worman H, et al. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology. 2001;33:16-21.
14. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-2576.
15. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389-2430.
16. Kim WR, Therneau TM, Benson JT, et al. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology. 2006;43:345-351.
17. Therneau TM, Grambsch PM, PatriciaM. Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag; 2000.
18. Massie AB, Caffo B, Gentry SE, et al. MELD exceptions and rates of waiting list outcomes. Am J Transplant. 2011;11:2362-2371.
19. Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant. 2010;10:1643-1648.
20. Goldberg D, French B, Abt P, et al. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl. 2012;18:434-443.